Der er utilstrækkelige oplysninger om brugen af salmeterol og fluticasonpropionat hos gravide og ammende kvinder til, at eventuel skadepåvirkning kan vurderes.
< Invented name > 50/ 100 microgram/ dose inhalation powder, pre-dispensed .< Invented name > 50/250 microgram/dose inhalation powder, pre-dispensed .< Invented name > 50/500 microgram/dose inhalation powder, pre-dispensed.